Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:00 pm Purchase | 2024-11-14 | 13D | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 5,745,834,167 10.850% | 2,332,672,000 (+68.34%) | Filing History |
| 2024-10-25 4:28 pm Purchase | 2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA | Patel Samir Rashmikant | 2,466,377 5.800% | 2,466,377 (New Position) | Filing History |
| 2024-06-07 6:00 pm Purchase | 2024-05-31 | 13D | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 3,413,162,167 14.500% | 3,413,162,167 (New Position) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 393,102 9.900% | 209,198 (+113.75%) | Filing History |
| 2022-02-14 08:02 am Purchase | 2021-12-31 | 13G | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 183,904 6.200% | 59,285 (+47.57%) | Filing History |
| 2021-02-16 08:31 am Purchase | 2020-12-31 | 13G | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 124,619 7.200% | 48,417 (+63.54%) | Filing History |